deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04527562

Colchicine in Moderate Symptomatic COVID-19 Patients (COLCOVIDBD)

Colchicine in Moderate Symptomatic COVID-19 Patients: Double Blind, Randomized, Placebo Controlled Trial to Observe the Efficacy

Sponsor: Dhaka Medical College

Conditions Covid19
Interventions Colchicine Placebo
Updated 5 times since 2020 Last updated: Jan 7, 2021 Started: Jul 14, 2020 Primary completion: Nov 15, 2020 Completion: Dec 10, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Covid19, this trial is completed. The trial is conducted by Dhaka Medical College and has accumulated 5 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotRecruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotRecruiting~Feb 2021 – ~Jul 2024 · 41 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Feb 2021 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  4. Jan 2021 — Feb 2021 [monthly]

    Recruiting NA

  5. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dhaka Medical College
Data source: Dhaka Medical College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations